The document is an intimation of an Analyst/Institutional Investor meeting, filed as a regulatory disclosure.
The event is a One-on-one Meeting with Entrust Family Office.
The meeting is scheduled for August 28, 2026, at 12:00 PM IST.
The meeting will be held virtually, with the venue listed as Bangalore.
The stated purpose of the event is a scheduled investor engagement, as per the details provided in the table.
The document does not specify if the meeting is scheduled before or after an earnings announcement.
No management participants or their designations are provided in the disclosure.
The company states that details of this intimation will be made available on the company website: www.syngeneintl.com.
The company has explicitly stated: "It is hereby notified that the Company shall not be disclosing any Unpublished Price Sensitive Information (UPSI) during the upcoming analyst/investor meeting."
No financial highlights, guidance references, or presentation summaries are included in this specific intimation document.
Additional Notes Section
This is a standalone regulatory letter of intimation. No attachments, such as a presentation deck or invite, are mentioned as being included with this filing.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The document is a compliance filing made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
